Article
Gene therapy for chronic granulomatous disease
1 Sept 2004
Abstract excerpt
Chronic granulomatous disease (CGD) is a congenital immune deficiency that is a promising therapeutic target for gene replacement into haematopoietic stem cells (HSCs). CGD results from mutations in any one of four genes encoding subunits of the superoxide-generating NADPH oxidase of phagocytes. Life-threatening, recurrent bacterial and fungal infections, as well as inflammatory granulomas, are the hallmarks of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
